Thu, July 27, 2023
Wed, July 26, 2023
Tue, July 25, 2023

Yigal Nochomovitz Maintained (SNDX) at Strong Buy with Increased Target to $35 on, Jul 26th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-35-on-jul-26th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Yigal Nochomovitz of Citigroup, Maintained "Syndax Pharmaceuticals, Inc." (SNDX) at Strong Buy with Increased Target from $31 to $35 on, Jul 26th, 2023.

Yigal has made no other calls on SNDX in the last 4 months.



There are 4 other peers that have a rating on SNDX. Out of the 4 peers that are also analyzing SNDX, 0 agree with Yigal's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Yigal


  • Kalpit Patel of "B. Riley Securities" Maintained at Strong Buy with Increased Target to $36 on, Tuesday, July 25th, 2023
  • Michael Schmidt of "Guggenheim" Maintained at Strong Buy with Increased Target to $42 on, Tuesday, July 25th, 2023
  • Edward White of "HC Wainwright & Co." Reiterated at Strong Buy with Increased Target to $38 on, Monday, July 24th, 2023
  • Justin Zelin of "BTIG" Maintained at Strong Buy with Increased Target to $35 on, Monday, June 26th, 2023

Publication Contributing Sources